190 related articles for article (PubMed ID: 30920070)
1. The association between proton pump inhibitor use and the risk of tuberculosis: A case-control study.
Song HJ; Park H; Park S; Kwon JW
Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):830-839. PubMed ID: 30920070
[TBL] [Abstract][Full Text] [Related]
2. Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study.
Tran-Duy A; Connell NJ; Vanmolkot FH; Souverein PC; de Wit NJ; Stehouwer CDA; Hoes AW; de Vries F; de Boer A
J Intern Med; 2019 Feb; 285(2):205-214. PubMed ID: 30141278
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
4. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
[TBL] [Abstract][Full Text] [Related]
5. Association between Proton Pump Inhibitors and Hearing Impairment: A Nested Case-Control Study.
Kim SY; Lee CH; Min C; Yoo DM; Choi HG
Curr Issues Mol Biol; 2021 May; 43(1):142-152. PubMed ID: 34070082
[TBL] [Abstract][Full Text] [Related]
6. Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study.
Hwang IC; Chang J; Park SM
PLoS One; 2018; 13(9):e0203918. PubMed ID: 30208110
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study.
Park JH; Song YM; Jung JH; Han K
Bone; 2020 Jun; 135():115306. PubMed ID: 32126312
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
Liang JF; Chen YT; Fuh JL; Li SY; Chen TJ; Tang CH; Wang SJ
Cephalalgia; 2015 Mar; 35(3):203-10. PubMed ID: 24853165
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
10. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
[TBL] [Abstract][Full Text] [Related]
11. The association between chronic rhinosinusitis and proton pump inhibitor use: a nested case-control study using a health screening cohort.
Choi HG; Kong IG
Sci Rep; 2022 Jun; 12(1):9554. PubMed ID: 35689002
[TBL] [Abstract][Full Text] [Related]
12. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
[TBL] [Abstract][Full Text] [Related]
13. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
Hong SH; Lee EK; Shin JY
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
[TBL] [Abstract][Full Text] [Related]
14. A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate.
Lee J; Youn K; Choi NK; Lee JH; Kang D; Song HJ; Park BJ
J Gastroenterol; 2013 Sep; 48(9):1016-22. PubMed ID: 23307040
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
Lin SM; Yang SH; Liang CC; Huang HK
Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor use associated with an increased risk of gout: A population-based case-control study.
Zhu KJ; Feng W; Ma XN; Liao PL; Lin CS; Huang JY; Wei JC; Xu Q
Int J Rheum Dis; 2023 Sep; 26(9):1799-1806. PubMed ID: 37470673
[TBL] [Abstract][Full Text] [Related]
17. Associations between proton pump inhibitors and Alzheimer's disease: a nested case-control study using a Korean nationwide health screening cohort.
Choi HG; Kim JH; Kim JH; Kim ES; Park HY; Min KW; Kwon MJ
Alzheimers Res Ther; 2022 Jul; 14(1):91. PubMed ID: 35773740
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of appendectomy in patients with gastroesophageal reflux disease: A nested case-control study using a national sample cohort.
Kim SY; Kim HJ; Lim H; Lim MS; Kim M; Choi HG
Medicine (Baltimore); 2018 Dec; 97(52):e13700. PubMed ID: 30593140
[TBL] [Abstract][Full Text] [Related]
19. Association between use of proton pump inhibitors and tuberculosis risk: a systematic review.
Song HJ; Park H; Seo HJ
Int J Tuberc Lung Dis; 2019 Aug; 23(8):943-951. PubMed ID: 31533885
[No Abstract] [Full Text] [Related]
20. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
